Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:0
|
作者
Megan Kunka Fritz
Scott E. Kincaid
Charles G. Sargent
Amanda H. Green
George A. Davis
机构
[1] University of Kentucky HealthCare,Pharmacy Department
[2] University of Kentucky HealthCare,Division of Hospital Medicine
[3] University of Kentucky HealthCare,Department of Nursing
[4] University of Kentucky HealthCare,Pharmacy Department
来源
Journal of Thrombosis and Thrombolysis | 2021年 / 51卷
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin;
D O I
暂无
中图分类号
学科分类号
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers’ VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined.Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection.Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study.A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
收藏
页码:67 / 73
页数:6
相关论文
共 50 条
  • [41] Medical Therapy in Venous Thromboembolism
    Eichinger, Sabine
    Kyrle, Paul A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (02) : 186 - 190
  • [42] Venous Thromboembolism Risk Stratification: The Missing Link in Hospitalized Patients
    Al-Ogaili, Ahmed
    Quintero, Luis Diaz
    Adum, Juan Pablo Salazar
    Fuentes, Harry E.
    Caprini, Joseph
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (11) : 1087 - 1088
  • [43] Risk of Venous Thromboembolism and Efficacy of Thromboprophylaxis in Hospitalized Obese Medical Patients and in Obese Patients Undergoing Bariatric Surgery
    Ana T Rocha
    Ângela G de Vasconcellos
    Epitácio R da Luz Neto
    Danilo M A Araújo
    Erivaldo S Alves
    Antônio Alberto Lopes
    Obesity Surgery, 2006, 16 : 1645 - 1655
  • [44] Primary prevention of venous thromboembolism in elderly medical patients
    Lacut, Karine
    Le Gal, Gregoire
    Mottier, Dominique
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (03) : 399 - 411
  • [45] Stratification of venous thromboembolism risk in stroke patients by Caprini score
    Zhu, Xiaoping
    Zhang, Tingting
    Zhou, Lanshu
    Yin, Xiaobing
    Dong, Qiong
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (03) : 631 - 636
  • [46] Venous thromboembolism in acutely ill hospitalized medical patients
    Barba, Raquel
    Zapatero, Antonio
    Losa, Juan E.
    Marco, Javier
    Plaza, Susana
    Canora, Jesus
    Manuel Casas, Jose
    THROMBOSIS RESEARCH, 2010, 126 (04) : 276 - 279
  • [47] Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE)
    Zhang, Xin
    Cai, Qiyan
    Wang, Xiaohui
    Liao, Ke
    Hu, Changchun
    Chen, Hong
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 863 - 871
  • [48] Risk stratification for cancer-associated venous thromboembolism
    Connolly, Gregory C.
    Khorana, Alok A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (01) : 35 - 47
  • [49] External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System
    Rosenberg, David
    Eichorn, Ann
    Alarcon, Mauricio
    McCullagh, Lauren
    McGinn, Thomas
    Spyropoulos, Alex C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (06):
  • [50] Prevention of Venous Thromboembolism in Medical Patients: Recent Advances and Future Directions
    Hellmann, Ilana
    Ellis, Martin H.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (12): : 753 - 757